Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson’s disease

References

• Elstner K, Selai CE, Trimble MR, Robertson MM. Quality of Life (QOL) of patients with Gilles de la Tourette’s syndrome. Acta Psychiatr. Scand.103(1), 52–59 (2001).
   PubMed Web of Science ®Google Scholar
• Liu W, McIntire K, Kim SH et al. Bilateral subthalamic stimulation improves gait initiation in patients with Parkinson’s disease. Gait Posture23(4), 492–498 (2006).
   PubMed Web of Science ®Google Scholar
• Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med.355(9), 896–908 (2006).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Oroz MC, Obeso JA, Lang AE et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain128(Pt 10), 2240–2249 (2005).
   PubMed Web of Science ®Google Scholar
• Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord.21(Suppl. 14), S290–S304 (2006).
   PubMed Web of Science ®Google Scholar
• Kumar R, Lang AE, Rodriguez-Oroz MC et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson’s disease. Neurology55(12 Suppl. 6), S34–S39 (2000).
   PubMedGoogle Scholar
• Loher TJ, Burgunder JM, Pohle T et al. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J. Neurosurg.96(5), 844–853 (2002).
   PubMed Web of Science ®Google Scholar
• Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov. Disord.16(3), 464–468 (2001).
   PubMed Web of Science ®Google Scholar
• Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson’s disease: results of a randomized, blinded pilot study. Neurosurgery45(6), 1375–1382 (1999).
   PubMed Web of Science ®Google Scholar
• Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N. Engl. J. Med.345(13), 956–963 (2001).
   PubMed Web of Science ®Google Scholar
• Krause M, Fogel W, Heck A et al. Deep brain stimulation for the treatment of Parkinson’s disease: subthalamic nucleus versus globus pallidus internus. J. Neurol. Neurosurg. Psychiatry70(4), 464–470 (2001).
   PubMed Web of Science ®Google Scholar
• Volkmann J, Allert N, Voges J et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology56(4), 548–551 (2001).
   PubMed Web of Science ®Google Scholar
• Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain121(Pt 3), 451–457 (1998).
   PubMed Web of Science ®Google Scholar
• Kenney C, Simpson R, Hunter C et al. Short-term and long-term safety of deep brain stimulation for the treatment of movement disorders. J. Neurosurg.106, 621–625 (2007).
   PubMed Web of Science ®Google Scholar
• Hariz MI. Complications of deep brain stimulation surgery. Mov. Disord.17(Suppl. 3), S162–S166 (2002).
   PubMed Web of Science ®Google Scholar
• Okun MS, Tagliati M, Pourfar M et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch. Neurol.62(8), 1250–1255 (2005).
   PubMed Web of Science ®Google Scholar
• Benabid AL, Chabardes S, Seigneuret E. Deep-brain stimulation in Parkinson’s disease: long-term efficacy and safety – what happened this year? Curr. Opin. Neurol.18(6), 623–630 (2005).
   PubMed Web of Science ®Google Scholar
• Weaver FM, Stern MB, Follett K. Deep-brain stimulation in Parkinson’s disease. Lancet Neurol.5(11), 900–901 (2006).
   PubMed Web of Science ®Google Scholar
• Eidelberg E, Walden JG, Nguyen LH. Locomotor control in macaque monkeys. Brain104(Pt 4), 647–663 (1981).
   PubMed Web of Science ®Google Scholar
• Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci.27(10), 585–588 (2004).
   PubMed Web of Science ®Google Scholar
• Jellinger K. The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry51(4), 540–543 (1988).
   PubMed Web of Science ®Google Scholar
• Semba K, Fibiger HC. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol.323(3), 387–410 (1992).
   PubMed Web of Science ®Google Scholar
• Shute CC, Lewis PR. The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain90(3), 497–520 (1967).
   PubMed Web of Science ®Google Scholar
• Spann BM, Grofova I. Origin of ascending and spinal pathways from the nucleus tegmenti pedunculopontinus in the rat. J. Comp. Neurol.283(1), 13–27 (1989).
   PubMed Web of Science ®Google Scholar
• Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson’s disease. Brain123(Pt 9), 1767–1783 (2000).
   PubMed Web of Science ®Google Scholar
• Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL. The pedunculopontine nucleus in Parkinson’s disease. Ann. Neurol.26(1), 41–46 (1989).
   PubMed Web of Science ®Google Scholar
• Lee MS, Rinne JO, Marsden CD. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med. J.41(2), 167–184 (2000).
   PubMed Web of Science ®Google Scholar
• Steininger TL, Rye DB, Wainer BH. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J. Comp. Neurol.321(4), 515–543 (1992).
   PubMed Web of Science ®Google Scholar
• Munro-Davies LE, Winter J, Aziz TZ, Stein JF. The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia. Exp. Brain Res.129(4), 511–517 (1999).
   PubMed Web of Science ®Google Scholar
• Matsumura M. The pedunculopontine tegmental nucleus and experimental parkinsonism. A review. J. Neurol.252(Suppl. 4), IV5–IV12 (2005).
   PubMedGoogle Scholar
• Jones DL, Mogenson GJ. Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. Am. J. Physiol.238(1), R65–R69 (1980).
   Google Scholar
• Mogenson GJ, Nielsen M. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav. Neural Biol.42(1), 38–51 (1984).
   PubMedGoogle Scholar
• Swerdlow N, Koob G. Neuronal substrates for the behavioral output of the nucleus accumbens. Life Sci.35, 2537–2544 (1984).
   PubMed Web of Science ®Google Scholar
• Garcia-Rill E. The pedunculopontine nucleus. Prog. Neurobiol.36(5), 363–389 (1991).
   PubMed Web of Science ®Google Scholar
• Dunbar JS, Hitchcock K, Latimer M et al. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions. Brain Res.589(2), 194–206 (1992).
   PubMed Web of Science ®Google Scholar
• Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ. Pedunculopontine nucleus stimulation improves akinesia in a parkinsonian monkey. Neuroreport15(17), 2621–2624 (2004).
   PubMed Web of Science ®Google Scholar
• Nandi D, Aziz TZ, Giladi N, Winter J, Stein JF. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain125(Pt 11), 2418–2430 (2002).
   PubMed Web of Science ®Google Scholar
• Takada M, Matsumura M, Kojima J et al. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation. Eur. J. Neurosci.12(5), 1771–1780 (2000).
   PubMed Web of Science ®Google Scholar
• Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport16(17), 1883–1887 (2005).
   PubMed Web of Science ®Google Scholar
• Mazzone P, Lozano A, Stanzione P et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson’s disease. Neuroreport16(17), 1877–1881 (2005).
   PubMed Web of Science ®Google Scholar
• Stefani A, Lozano AM, Peppe A et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Thomas M, Jankovic J, Suteerawattananon M et al. Clinical gait and balance scale (GABS): validation and utilization. J. Neurol. Sci.217(1), 89–99 (2004).
   PubMed Web of Science ®Google Scholar